Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2710011rdf:typepubmed:Citationlld:pubmed
pubmed-article:2710011lifeskim:mentionsumls-concept:C0023895lld:lifeskim
pubmed-article:2710011lifeskim:mentionsumls-concept:C0008188lld:lifeskim
pubmed-article:2710011lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:2710011pubmed:issue1lld:pubmed
pubmed-article:2710011pubmed:dateCreated1989-5-26lld:pubmed
pubmed-article:2710011pubmed:abstractTextChlordiazepoxide 40mg daily was used to prevent delerium tremens in a 64-year-old female with alcoholic liver disease. After 20 days, the drug was stopped because of the onset of progressive drowsiness. The kinetics of chloridazepoxide were within the predicted range for patients with liver disease, but the elimination half-lives of desmethylchlordiazepoxide and demoxepam were greatly prolonged at 346 hours and 150 hours, respectively. It is suggested that metabolite accumulation may have contributed to the coma, which is an unusual reaction to chlordiazepoxide.lld:pubmed
pubmed-article:2710011pubmed:languageenglld:pubmed
pubmed-article:2710011pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2710011pubmed:citationSubsetIMlld:pubmed
pubmed-article:2710011pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2710011pubmed:statusMEDLINElld:pubmed
pubmed-article:2710011pubmed:issn0112-5966lld:pubmed
pubmed-article:2710011pubmed:authorpubmed-author:NichollsD PDPlld:pubmed
pubmed-article:2710011pubmed:authorpubmed-author:ScottM GMGlld:pubmed
pubmed-article:2710011pubmed:authorpubmed-author:BartowBBlld:pubmed
pubmed-article:2710011pubmed:authorpubmed-author:AuldP WPWlld:pubmed
pubmed-article:2710011pubmed:issnTypePrintlld:pubmed
pubmed-article:2710011pubmed:volume4lld:pubmed
pubmed-article:2710011pubmed:ownerNLMlld:pubmed
pubmed-article:2710011pubmed:authorsCompleteYlld:pubmed
pubmed-article:2710011pubmed:pagination73-6lld:pubmed
pubmed-article:2710011pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2710011pubmed:meshHeadingpubmed-meshheading:2710011-...lld:pubmed
pubmed-article:2710011pubmed:meshHeadingpubmed-meshheading:2710011-...lld:pubmed
pubmed-article:2710011pubmed:meshHeadingpubmed-meshheading:2710011-...lld:pubmed
pubmed-article:2710011pubmed:meshHeadingpubmed-meshheading:2710011-...lld:pubmed
pubmed-article:2710011pubmed:meshHeadingpubmed-meshheading:2710011-...lld:pubmed
pubmed-article:2710011pubmed:meshHeadingpubmed-meshheading:2710011-...lld:pubmed
pubmed-article:2710011pubmed:meshHeadingpubmed-meshheading:2710011-...lld:pubmed
pubmed-article:2710011pubmed:meshHeadingpubmed-meshheading:2710011-...lld:pubmed
pubmed-article:2710011pubmed:articleTitleChlordiazepoxide metabolite accumulation in liver disease.lld:pubmed
pubmed-article:2710011pubmed:affiliationRoyal Victorial Hospital, Belfast, Northern Ireland.lld:pubmed
pubmed-article:2710011pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2710011pubmed:publicationTypeCase Reportslld:pubmed